NASDAQ:LIMN | Free Cash Flow | Liminatus Pharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.02M
2025-12-31-$386,847.00$0.00-$386,847.00
2025-03-31-$159,393.00
2024-12-31-$140,660.00
2024-03-31$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.96M$13,108.00-$9.98M
2024-12-31-$1.45M